>>>
>>> WELCOME BACK. WE WANTED TO LEARN MORE ABOUT
THIS ROUND BREAKING STUDY AND
THE TREATMENT OF BREAST CANCER.
CHEMOTHERAPY IS NOT NECESSARY
AND MOST CASES.
WE ARE HAPPY TO HAVE A DOCTOR
HERE FROM THE CANCER INSTITUTE.
THIS IS RECEIVED SO MUCH
ATTENTION.
ATTENTION. WHAT YOU WANT US TO KNOW?
>> I WANT WOMEN TO UNDERSTAND
THE BEST CANCER IS NOT LIKE
LUNG DISEASE.
LUNG DISEASE. IT IS AS DIVERSE AS THE WOMEN
WHO GET IT.
WE ARE TAILORING THERAPY.
THIS EMPHASIZES THAT NEED TO
BRING THERAPIES THAT TREAT
TUMORS SPECIFICALLY.
TUMORS SPECIFICALLY. >> WHAT IS THE ALTERNATIVE
TREATMENT?
TREATMENT? >> EVERYONE GOT ENDOCRINE
THERAPY.
THERAPY.
THERAPY. THAT IS STARVING THE TUMOR OF
ESTROGEN.
ESTROGEN.
ESTROGEN. NOT ALLOWING THOSE CELLS TO SET
UP SHOP SOMEPLACE ELSE.
>> AS FAR AS WHAT THE STUDY
SHOWED, THE NUMBER SAYS -- SAY
85% DID NOT CHEMOTHERAPY?
>> 85% OF WOMEN WITH DIAGNOSED
-- WITH BREAST CANCER MAY NOT
NEED CHEMOTHERAPY.
NEED CHEMOTHERAPY. THAT IS EXCITING.
THIS NEW THERAPY WILL BE VERY
POWERFUL FOR THEM.
>> THEY WON'T HAVE THOSE SIDE
EFFECTS.
EFFECTS.
EFFECTS. >> RIGHT.
>> RIGHT.
>> RIGHT. IT IS MORE TARGETED.
IT IS A PILL YOU TAKE EVERY
DAY.
DAY.
DAY. IT
DAY. IT IS A MARATHON.
YOU TAKE IT FOR FIVE YEARS.
WOMEN SIGN UP FOR COMMITMENT
BUT IT IS VERY POWERFUL.
IT DOES NOT HAVE THE
DEVASTATING SIDE EFFECTS OF
OTHER THERAPY.
OTHER THERAPY. PATIENTS GET THROUGH THIS
EASIER?
EASIER?
EASIER? >> YES.
>> YES.
>> YES. CANCER THERAPY, THAT IS
ASSOCIATED WITH CHEMOTHERAPY.
THIS HAS MINOR SIDE EFFECTS.
MOST WOMEN TOLERATED VERY WELL.
>> MY THOUGHT GOES TO WOMEN
HEARING THIS WHO WENT THROUGH
CHEMOTHERAPY AND THEY ASK IF
THEY HAVE NEEDED IT.
>> I WANT TO REINSURE THEM THAT
IN MANY CASES, YOU DID.
IT WAS AN EXCELLENT WAY TO KILL
THE TUMOR CELLS.
IT SAVES LIVES.
THERE ARE MANY WOMEN FOR WHOM
THIS WILL STILL BE AN ESSENTIAL
PART OF THEIR TREATMENT.
THAT IS WOMEN WITH TRIPLE
NEGATIVE CANCERS, HIGH RISK
POSITIVE TUMOR -- COULD TUMORS
AND YOUNG WOMEN.
IT SAVES LIVES.
>> IT IS SOMETHING THAT IS
STILL IMPORTANT.>> DO YOU
ANTICIPATE OTHER DOCTORS
CHANGING SOON?
CHANGING SOON? IS THIS GOING TO TAKE YEARS?
>> WE HAVE CHANGED FACTORS --
PRACTICE.
PRACTICE.
PRACTICE. I HAVE CALLED PATIENTS TO LET
THEM KNOW THAT CHEMOTHERAPY
WOULD NOT BE IN THEIR FUTURE
BASED ON THE RESULTS OF THIS
TEST.
TEST.
TEST. WE
TEST. WE COULD FEEL MORE CONFIDENT IN
OUR DECISION-MAKING GOING
FORWARD.
FORWARD.
FORWARD. IT IS IMPORTANT TO KNOW THAT WE
WON'T BE DRASTICALLY CHANGING
HOW WE TREAT PEOPLE. THIS HELPS
US HAVE MORE CONFIDENCE IN THE
WAY THAT WE HAVE BEEN TREATING
WOMEN.
WOMEN.
WOMEN. >>
WOMEN. >> JUST TO MAKE SURE THAT WOMEN
HAVE THE RIGHT INFORMATION,
WHAT ABOUT THIS THAT HE
DETERMINED THAT?
DETERMINED THAT? >> HE LOOKED AT THE RESULTS.
THEY TAKE A PORTION OF THE
TUMOR AND LOOK AT THE GENETIC
WORKINGS OF THE CELLS.
THE SPECIFIC GENETICS OF THE
TUMOR.
TUMOR.
TUMOR. THEY LOOK AT HOW BUSY THEY ARE.
DO THEY HAVE QUALITIES THAT
MAKE THEM MORE THREATENING?
THEN, THEY DIVIDE THEM INTO
THREE GROUPS.
THREE GROUPS. LOW RISK TUMORS ARE WOMEN WHO
DO NOT NEED CHEMOTHERAPY.
HIGH RISK TUMORS, THOSE WOMEN
DID NEED CHEMOTHERAPY.
THE VAST MAJORITY FALL INTO
THAT INTERMEDIATE GROUP.
UNTIL NOW, WE DID KNOW WHAT TO
DO.
DO.
DO. THIS
DO. THIS STUDY SHOWS US THAT IT IS
SAFE TO ADMIT CHEMOTHERAPY IN
THE INTERMEDIATE GROUP BECAUSE
THOSE WOMEN WILL BE WELL
TREATED WITH THE OTHER THERAPY.
>> THIS WILL BE DIFFERENT CASE
TO CASE.
TO CASE.
TO CASE. IS THIS A FASTER RECOVERY
PROCESS?
PROCESS?
PROCESS? >> OH YES.
WOMEN, IT IS A PILL THAT YOU
TAKE DAILY.
TAKE DAILY. YOU START TAKING THAT AFTER YOU
HAVE RECOVERED FROM SURGERY AND
RADIATION.
RADIATION. IT GOES FIVE TO 10 YEARS
DEPENDING ON YOUR TYPE OF
TUMOR.
TUMOR.
TUMOR. >>
TUMOR. >> THIS IS COVERED BY
INSURANCE?
INSURANCE? >> YES.
>> YES.
>> YES. >> FASCINATING.
>> FASCINATING. WE THANK YOU SO MUCH.
>> I'M GLAD YOU SHARED THAT.
I KNOW